Vectus Biosystems (ASX:VBS) ROE % Adjusted to Book Value : -11.99% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems ROE % Adjusted to Book Value?

Vectus Biosystems's ROE % for the quarter that ended in Dec. 2023 was -79.95%. Vectus Biosystems's PB Ratio for the quarter that ended in Dec. 2023 was 6.67. Vectus Biosystems's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -11.99%.

Vectus Biosystems ROE % Adjusted to Book Value Historical Data

The historical data trend for Vectus Biosystems's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems ROE % Adjusted to Book Value Chart

Vectus Biosystems Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-30.92

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												-	-82.13	-9.40	-11.99	-43.76

Competitive Comparison of Vectus Biosystems's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Vectus Biosystems's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vectus Biosystems's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's ROE % Adjusted to Book Value falls into.

Vectus Biosystems ROE % Adjusted to Book Value Calculation

Vectus Biosystems's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	6.67
	=	0.00%

Vectus Biosystems's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-79.95%	/	6.67
	=	-11.99%

Vectus Biosystems ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018

Website

https://www.vectusbiosystems.com.au

Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. It operates in one segment, being pharmaceutical research and development.

Vectus Biosystems Headlines

No Headlines